-+ 0.00%
-+ 0.00%
-+ 0.00%

This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Benzinga·04/25/2025 12:26:59
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Canaccord Genuity analyst Joseph Vafi downgraded the rating for ASGN Incorporated (NYSE:ASGN) from Buy to Hold and lowered the price target from $115 to $55. ASGN shares closed at $51.76 on Thursday. See how other analysts view this stock.
  • JP Morgan analyst Alexei Gogolev downgraded SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) from Overweight to Neutral and lowered the price target from $90 to $86. SS&C Technologies shares closed at $77.43 on Thursday. See how other analysts view this stock.
  • Macquarie analyst Linda Huang downgraded the rating for TAL Education Group (NYSE:TAL) from Outperform to Neutral and cut the price target from $14.5 to $10.9. TAL Education shares closed at $8.93 on Thursday. See how other analysts view this stock.
  • Wells Fargo analyst Tiago Fauth downgraded United Therapeutics Corporation (NASDAQ:UTHR) from Overweight to Equal-Weight and slashed the price target from $395 to $314. United Therapeutics shares closed at $296.42 on Thursday. See how other analysts view this stock.

Considering buying UTHR stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock